[1]王铁华,郑景辉,莫云秋.蛋白质组学在心肌梗死中的研究进展[J].心血管病学进展,2015,(5):616-616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
 WANG Tiehua,ZHENG Jinghui,MO Yunqiu.Research Progress of Proteomics in Myocardial Infarction[J].Advances in Cardiovascular Diseases,2015,(5):616-616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
点击复制

蛋白质组学在心肌梗死中的研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2015年5期
页码:
616-616
栏目:
综述
出版日期:
2016-05-20

文章信息/Info

Title:
Research Progress of Proteomics in Myocardial Infarction
作者:
王铁华1郑景辉2莫云秋2
1. 广西中医药大学, 广西 南宁 530001; 2. 广西中医药大学附属瑞康医院, 广西 南宁 530011
Author(s):
WANG Tiehua1ZHENG Jinghui2MO Yunqiu2
1. Guangxi University of Chinese Medicine,Nanning 530001,Guangxi,China; 2. Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530011,Guangxi,China
关键词:
心肌梗死 蛋白质组学 组织 血液
Keywords:
myocardial infarction proteomics tissue blood
分类号:
R541.4
DOI:
10.3969/j.issn.1004-3934.2015.05.024
文献标志码:
A
摘要:
心肌梗死是一种高致残率和致死率的疾病之一。其机制的初步探明已经为疾病的预防、诊断、药物靶点和治疗提供一些重要的信息,但更深层次的分子机制未明。该研究概述了动物模型与人类的心肌梗死组织蛋白质组学的研究进展,以及动物模型与人类的心肌梗死血清蛋白质组学的研究进展,并就心肌梗死蛋白质组学存在的问题以及发展方向进行探讨。
Abstract:
Myocardial infarction is a high morbidity and mortality disease. Its molecular mechanisms have initially provided important information for disease detection,diagnosis and rehabilitation,however,its mechanism is unknown at a deeper level. This study summarized the research progress of the animal model with human myocardial infarction tissue proteomics. As well the animal model with human myocardial infarction blood serum proteomics and existing problems and development direction in myocardial infarction proteomics were discussed.

参考文献/References:

[1] Wilkins MR,Sanchez JC,Gooley AA,et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it[J]. Biotechnol Genet Eng Rev, 1996,13:19-50.
[2] Oda Y, Nagasu T, Chait BT. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome[J]. Nat Biotechnol,2001,19(4):379-382.
[3] de Celle T, Vanrobaeys F, Lijnen P, et al. Alterations in mouse cardiac proteome after in vivo myocardial infarction:permanent ischaemia versus ischaemia reperfusion[J]. Exp Physiol,2005, 90(4):593-606.
[4] White MY, Cordwell SJ, McCarron HC,et al. Proteomics of ischemia/reperfusion injury in rabbit myocardium reveals alterations to proteins of essential functional systems[J]. Proteomics,2005, 5(5):1395-1410.
[5] 赵艳峰,叶能胜,张荣利,等.中国小型猪心肌梗死模型的比较蛋白质组学研究[J]. 高等学校化学学报,2006,27(8):1467-1471.
[6] Chen CH, Budas GR, Churchill EN, et al. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart[J]. Science,2008,321(5895):1493-1495.
[7] 张翠丽,许玲,王波,等.大鼠心肌梗死后差异蛋白质组学分析[J]. 现代生物医学进展,2011, 11(2):230-232.
[8] Dorn GW. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling[J]. Cardiovasc Res,2009,81(3):465-473.
[9] Hori M, Nishida K. Oxidative stress and left ventricular remodeling after myocardial infarction[J]. Cardiovasc Res,2008,81:457-464.
[10] Xiang F, Shi Z, Guo X, et al. Proteomic analysis of myocardial tissue from the border zone during early stage post-infarct remodelling in rats[J]. Eur J Heart Fail,2011,13(3):254-263.
[11] Langley SR, Dwyer J, Drozdov I, et al. Proteomics:from single molecules to biological pathways[J]. Cardiovasc Res,2013,97(4):612-622.
[12] Bagnato C, Thumar J, Mayya V, et al. Proteomics analysis of human coronary atherosclerotic plaque:a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry[J]. Mol Cell Proteomics,2007,6(6):1088-1102.
[13] Kakimoto Y, Ito S, Abiru H, et al. Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase:proteomic analysis of cardiac tissues from patients[J]. J Am Heart Assoc,2013,2(6):e000565.
[14] Sakai J, Ishikawa H, Kojima S, et al. Proteomic analysis of rat heart in ischemia and ischemia-reperfusion using fluorescence two-dimensional difference gel electrophoresis[J]. Proteomics,2003,3(7):1318-1324.
[15] 刘蕾,王伟,宋剑南,等.心肌缺血小型猪模型差异蛋白质组学研究[J]. 南京医科大学学报:自然科学版,2009,29(4):459-463.
[16] 王勇,啜文静,郭淑贞,等.基于小型猪冠心病心肌缺血模型的血瘀证蛋白组学研究[J]. 北京中医药大学学报,2011,34(7):460-464.
[17] Barderas MG,Tuñón J,Dardé VM,et al.Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile[J]. J Proteome Res,2007,6(2):876-886.
[18] Parguiña AF, Grigorian-Shamajian L, Agra RM,et al. Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome:a proteomic study[J]. PLoS One,2010,5(10):e13404.
[19] 高春芳,郑国宝,赵光,等.急性心肌梗死病程不同时期患者血清蛋白质组学分析[J]. 解放军医学杂志,2005,30(6):465-466.
[20] Guo W,Xue J,Shi J,et al.Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patients[J]. J Proteome Res,2010,9(8):4170-4175.
[21] Martinez-Pinna R, Madrigal-Matute J, Tarin C, et al. Proteomic analysis of intraluminal thrombus highlights complement activation in human abdominal aortic aneurysms[J]. Arterioscler Thromb Vasc Biol,2013,33(8):2013-2020.
[22] You SA, Archacki SR, Angheloiu G, et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis[J]. Physiol Genomics,2003,13(1):25-30.
[23] Distelmaier K, Adlbrecht C, Jakowitsch J, et al. Proteomic profiling of acute coronary thrombosis reveals a local decrease in pigment epithelium-derived factor in acute myocardial infarction[J]. Clin Sci,2012,123(2):111-119.
[24] Alonso-Orgaz S, Moreno-Luna R, López JA, et al. Proteomic characterization of human coronary thrombus in patients with ST-segment elevation acute myocardial infarction[J]. J Proteomics,2014,109:368-381.
[25] Erogbogbo F, May J, Swihart M, et al. Bioengineering silicon quantum dot theranostics using a network analysis of metabolomic and proteomic data in cardiac ischemia[J]. Theranostics, 2013,3(9):719-728.
[26] Vélez P, Parguiña AF, Ocaranza-Sánchez R, et al. Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction[J]. Thromb Haemost,2014, 112(4):716-726.

相似文献/References:

[1]孙洋.基质金属蛋白酶与心肌梗死后心脏重构[J].心血管病学进展,2019,(8):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
 SUN Yang.Matrix Metalloproteinases in Cardiac Remodeling after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(5):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
[2]陈丰 苏强 朱继金.高迁移率族蛋白B1在心脏炎症反应性疾病中的研究进展[J].心血管病学进展,2019,(8):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
 CHEN Feng,SU Qiang,ZHU Jijin.Research Progress of HMGB1 in Myocardial Inflammatory Reactivity Disease[J].Advances in Cardiovascular Diseases,2019,(5):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
[3]常文婧 王丽娜.Hippo通路在心脏发育、再生和疾病中的作用[J].心血管病学进展,2019,(8):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
 CHANG Wenjin,WANG Lina.Role of Hippo Pathway in Heart Development,Regeneration and Disease[J].Advances in Cardiovascular Diseases,2019,(5):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
[4]王宇 周思维 张莎 吴弘.植入型心律转复除颤器在心肌梗死后心脏性猝死中的研究进展[J].心血管病学进展,2020,(1):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
 WANG Yu,ZHOU Siwei,ZHANG Sha,et al.Implantable Cardioverter Defibrillator in Sudden Cardiac Death after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(5):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
[5]邹先明 赵然尊.长链非编码RNA ANRIL与心血管疾病的研究进展[J].心血管病学进展,2020,(2):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
 ZOU Xianming,ZHAO Ranzun.Long Non-Coding RNA ANRIL and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(5):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
[6]王茜 李晶洁.细胞学机制在调控心肌梗死后炎症反应中的研究进展[J].心血管病学进展,2020,(2):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
 WANG QianLI Jingjie.Cytological Mechanisms in Regulation of The Post-infarction Inflammatory Response[J].Advances in Cardiovascular Diseases,2020,(5):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
[7]黄柳,张瑞宁,田小超,等.内皮祖细胞与冠心病患者CD14CD16+单核细胞共培养后移植心肌梗死大鼠对血管密度及心肌梗死面积的影响[J].心血管病学进展,2020,(2):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
 HUANG Liu,ZHANG Ruining,TIAN Xiaochao,et al.Effects of Co-cultured Endothelial Progenitor Cells and CD14++CD16+ Monocytes from Coronary Heart Disease Patients on Vascular Density and Myocardial Infarction Size in Transplanting Myocardial Infarction Rats[J].Advances in Cardiovascular Diseases,2020,(5):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
[8]刘玉婷,贾锋鹏.骨膜蛋白与心血管疾病的研究进展[J].心血管病学进展,2020,(3):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
 LIU Yuting,JIA Fengpeng.Roles of Periostin in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(5):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
[9]谢建华,赵鸿泽,刘剑雄.MicroRNA在心肌梗死后左室重塑和心力衰竭发展中的研究现状[J].心血管病学进展,2020,(3):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
 XIE Jianhua,ZHAO Hongze,LIU Jianxiong.MicroRNA in Development of Left Ventricular Remodeling and Heart Failure after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(5):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
[10]杜冲 韦文 李亚飞 王连生.心肌梗死后心肌细胞内源再生的研究进展[J].心血管病学进展,2020,(4):395.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.017]
 DU Chong,WEI Tianwen,LI Yafei,et al.Endogenous Regeneration of Myocardial Cells after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(5):395.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.017]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81360535); 广西科学研究与技术开发计划项目(桂科合1347004-26); 广西自然科学基金课题(2013GXNSFAA019126) 作者简介:王铁华(1989—),硕士,主要从事冠心病介入治疗的研究。Email: visaly520@163.com 通信作者:莫云秋,主任医师,硕士,主要从事心血管疾病防治研究。Email: moyq3785@126.com
更新日期/Last Update: 2016-05-20